SKF-89976A is an anticonvulsant, acting as a GABA reuptake inhibitor via blockade of GAT-1.
Synthesis
Ex 1: Finkelstein Sn2 alkylation between 1,1-Diphenyl-4-bromobutene [6078-95-1] (1) & Ethyl nipecotate [5006-62-2] (2) gives [89203-62-3] (3). Optional saponification of the ester group gives the title amino-acid compound (4).
Related compounds
References
External links Borden, L. A.; Murali Dhar, T. G.; Smith, K. E.; Weinshank, R. L.; Branchek, T. A.; Gluchowski, C. (1994). "Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1". European Journal of Pharmacology. 269 (2): 219–224. doi:10.1016/0922-4106(94)90089-2. PMID 7851497.


![SKF-89976A: Synthesis:[2][3] Patent:[4][5]](https://upload.wikimedia.org/wikipedia/commons/thumb/1/18/SKF-89976A_synthesis.svg/500px-SKF-89976A_synthesis.svg.png?utm_source=en.wikipedia.org&utm_campaign=parser&utm_content=thumbnail)
![SKF-89976A: NNC-47-0011:[6] Patent:[7]](https://upload.wikimedia.org/wikipedia/commons/thumb/b/b3/NNC-47-0011.svg/500px-NNC-47-0011.svg.png?utm_source=en.wikipedia.org&utm_campaign=parser&utm_content=thumbnail)
